Using the Best Interests Standard to Decide Whether to Test Children for Untreatable, Late-Onset Genetic Diseases

ISSN： 0360-5310

Source： The Journal of Medicine and Philosophy, Vol.32, Iss.4, 2007-07, pp. : 375-394

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Using the Best Interests Standard to Generate Actual Duties

By Kopelman Loretta M.

AJOB Primary Research, Vol. 4, Iss. 2, 2013-04 ,pp. : 11-14

Taylor & Francis Ltd

Access to resources Recommend Favorite

THE RELEVANCE OF GENETIC TESTING IN LATE‐ONSET HUNTINGTON'S DISEASE

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 44, Iss. 5, 1996-05 ,pp. : 609-611

John Wiley & Sons Inc

Access to resources Recommend Favorite

Monitoring late-onset toxicities in phase I trials using predicted risks

By Bekele B. Nebiyou Ji Yuan Shen Yu Thall Peter F.

Biostatistics, Vol. 9, Iss. 3, 2008-07 ,pp. : 442-457

Oxford University Press

Access to resources Recommend Favorite

Rejecting the Baby Doe Rules and Defending a “Negative” Analysis of the Best Interests Standard

By Kopelman Loretta

The Journal of Medicine and Philosophy, Vol. 30, Iss. 4, 2005-08 ,pp. : 331-352

Oxford University Press

Access to resources Recommend Favorite

Cannabinoids in late‐onset Alzheimer's disease

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 97, Iss. 6, 2015-06 ,pp. : 597-606

John Wiley & Sons Inc

Access to resources Recommend Favorite